Table 3. Correlation analysis of the clinical characteristics and the twenty-three gene signature in LUAD.
| Characteristics | TCGA training cohort (n = 445) | GSE30219 testing cohort (n = 83) | GSE72094 testing cohort (n = 393) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Mean (rick score) | SD | t | P | n | Mean (rick score) | SD | t | P | n | Mean (rick score) | SD | t | P | |
| Age(years) | |||||||||||||||
| <68 | 247 | 0.765 | 0.64 | −0.164 | 0.87 | 23 | 0.543 | 0.346 | −0.088 | 0.931 | 153 | 1.253 | 0.93 | −0.524 | 0.600 |
| ≥68 | 198 | 0.775 | 0.663 | 60 | 0.55 | 0.272 | 240 | 1.305 | 1.04 | ||||||
| Gender | |||||||||||||||
| Female | 244 | 0.702 | 0.611 | −2.393 | 0.017 | 19 | 0.535 | 0.357 | −0.183 | 0.856 | 219 | 1.203 | 1.012 | −1.850 | 0.065 |
| Male | 201 | 0.851 | 0.686 | 64 | 0.552 | 0.274 | 174 | 1.389 | 0.972 | ||||||
| TNM stage | |||||||||||||||
| Stage I+II | 348 | 0.68 | 0.584 | −4.822 | <0.001 | 60 | 0.456 | 0.235 | −6.598 | <0.001 | 320 | 1.166 | 0.842 | −3.771 | <0.001 |
| Stage III+IV | 97 | 1.083 | 0.765 | 23 | 0.875 | 0.239 | 73 | 1.805 | 1.392 | ||||||
| T | |||||||||||||||
| T1+2 | 387 | 0.716 | 0.595 | −3.5 | 0.001 | 73 | 0.528 | 0.299 | −2.479 | 0.024 | – | – | – | – | – |
| T3+4 | 58 | 1.125 | 0.86 | 10 | 0.697 | 0.185 | – | – | – | ||||||
| N | |||||||||||||||
| N0 | 292 | 0.71 | 0.639 | −2.629 | 0.009 | 71 | 0.502 | 0.276 | −4.03 | 0.001 | – | – | – | – | – |
| N1-3 | 153 | 0.881 | 0.657 | 12 | 0.817 | 0.245 | – | – | – | ||||||
| M | |||||||||||||||
| M0 | 403 | 0.742 | 0.64 | −2.577 | 0.013 | 67 | 0.468 | 0.241 | −5.959 | <0.001 | – | – | – | – | – |
| M1 | 42 | 1.028 | 0.689 | 16 | 0.881 | 0.251 | – | – | – | ||||||
Notes.
- SD
- standard deviation
- TNM
- tumornode metastasis